DE69023721T2 - In 3-Position Nitro-substituierte Steroid-Derivate. - Google Patents

In 3-Position Nitro-substituierte Steroid-Derivate.

Info

Publication number
DE69023721T2
DE69023721T2 DE69023721T DE69023721T DE69023721T2 DE 69023721 T2 DE69023721 T2 DE 69023721T2 DE 69023721 T DE69023721 T DE 69023721T DE 69023721 T DE69023721 T DE 69023721T DE 69023721 T2 DE69023721 T2 DE 69023721T2
Authority
DE
Germany
Prior art keywords
alpha
steroid derivatives
substituted steroid
hydrogen
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69023721T
Other languages
English (en)
Other versions
DE69023721D1 (de
Inventor
Dennis Alan Holt
Mark Alan Levy
Brian Walter Metcalf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
SmithKline Beecham Corp
Original Assignee
GlaxoSmithKline LLC
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline LLC, SmithKline Beecham Corp filed Critical GlaxoSmithKline LLC
Publication of DE69023721D1 publication Critical patent/DE69023721D1/de
Application granted granted Critical
Publication of DE69023721T2 publication Critical patent/DE69023721T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69023721T 1989-08-23 1990-08-22 In 3-Position Nitro-substituierte Steroid-Derivate. Expired - Fee Related DE69023721T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/397,615 US4970204A (en) 1989-08-23 1989-08-23 3-substituted nitro-steroid derivatives as 5-α-reductase inhibitors

Publications (2)

Publication Number Publication Date
DE69023721D1 DE69023721D1 (de) 1996-01-04
DE69023721T2 true DE69023721T2 (de) 1996-04-25

Family

ID=23571932

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69023721T Expired - Fee Related DE69023721T2 (de) 1989-08-23 1990-08-22 In 3-Position Nitro-substituierte Steroid-Derivate.

Country Status (12)

Country Link
US (1) US4970204A (de)
EP (1) EP0414530B1 (de)
JP (1) JPH03118325A (de)
KR (1) KR910004652A (de)
AT (1) ATE130619T1 (de)
AU (1) AU640161B2 (de)
CA (1) CA2023610A1 (de)
DE (1) DE69023721T2 (de)
IE (1) IE903032A1 (de)
NZ (1) NZ235001A (de)
PT (1) PT95089A (de)
ZA (1) ZA906666B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215894A (en) * 1992-02-25 1993-06-01 Merck & Co., Inc. Biological process for producing 17β-N-monosubstituted carbamoyl-11-oxo-4-aza-5-α-androst-3-one testosterone-5-α reductase inhibitors
JPH0641038A (ja) 1992-07-17 1994-02-15 Mitsubishi Kasei Corp カルボン酸誘導体
GB9224148D0 (en) * 1992-11-18 1993-01-06 Smithkline Beecham Corp Compounds
US5561124A (en) * 1992-11-18 1996-10-01 Webb; Robert L. 17-α-acyl steroids which inhibit 5-α-reductase
CA2386095A1 (en) 1999-09-30 2001-04-05 Hollis-Eden Pharmaceuticals, Inc. Therapeutic treatment of androgen receptor driven conditions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4191759A (en) * 1978-04-13 1980-03-04 Merck & Co., Inc. N-substituted-17β-carbamoylandrost-4-en-3-one 5α reductase inhibitors
US4377584A (en) * 1978-04-13 1983-03-22 Merck & Co., Inc. 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
US4317817A (en) * 1979-08-27 1982-03-02 Richardson-Merrell Inc. Novel steroid 5α-reductase inhibitors
DK465481A (da) * 1980-11-21 1982-05-22 Hoffmann La Roche Fremgangsmaade til fremstilling af d-homostemoider
US4814324A (en) * 1987-03-06 1989-03-21 Merck & Co., Inc. Sterol inhibitors of testosterone 5α-reductase
US4910226A (en) * 1987-04-29 1990-03-20 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors
US5026882A (en) * 1988-12-23 1991-06-25 Smithkline Beecham Corporation Phosphinic acid substituted steroids as inhibitors of steroid 5α-reductase
US4946834A (en) * 1988-12-23 1990-08-07 Smithkline Beecham Corporation Phosphonic acid substituted steroids as steroid 5α-reductase inhibitors

Also Published As

Publication number Publication date
US4970204A (en) 1990-11-13
EP0414530A3 (en) 1991-07-24
EP0414530B1 (de) 1995-11-22
JPH03118325A (ja) 1991-05-20
DE69023721D1 (de) 1996-01-04
AU6115190A (en) 1991-02-28
CA2023610A1 (en) 1991-02-24
EP0414530A2 (de) 1991-02-27
KR910004652A (ko) 1991-03-29
IE903032A1 (en) 1991-02-27
ZA906666B (en) 1991-09-25
NZ235001A (en) 1993-01-27
ATE130619T1 (de) 1995-12-15
AU640161B2 (en) 1993-08-19
PT95089A (pt) 1991-04-18

Similar Documents

Publication Publication Date Title
DK0414529T3 (da) Substituerede steroidderivater
DK73594A (da) Fremgangsmåde til fremstilling af 17-substituerede 4-aza-5,7-androstadien-3-on-derivater
ES2039278T3 (es) Procedimiento para preparar inhibidores de 5-alfa-reductasa de esteroides.
MX9301525A (es) Esteriodes substituidos en la posicion 17 y composicion farmaceutica que los contiene.
DK8885D0 (da) N-heterocyclyl-4-piperidinaminderivater og fremgangsmaade til fremstilling deraf
GR900100380A (el) Μέ?οδος παρασκευής αντι-φλεγμονωδών παραγώγων αμινοφενόλης.
SE8103988L (sv) 10-(1,2-propadienyl)steroider och kompositioner innehallande desamma, med terapeutisk anvendning
ATE130619T1 (de) In 3-position nitro-substituierte steroid- derivate.
HUT55385A (en) Process for producing 3-piperazinyl-benzazol derivatives and pharmaceutical compositions containing them as active components
ES415753A1 (es) Procedimiento de obtencion de composiciones basadas en mo- leculas biologicamente activas para combatir caries dentalesy enfermedades periodontales.
AU641686B2 (en) Benzanilides
GB1399261A (en) 1,3-diamino 2-propanols and process for their preparation
NO872115L (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive steroider.
IT1210926B (it) Derivati della 1-metil-5-nitro-imidazolina e composizioni terapeutiche che li comprendono come principio attivo.
ES2087173T3 (es) Uso de derivados de piridoindol en el tratamiento de enfermedades isquemicas.
ES2045502T3 (es) Derivados de benzopirrolidinona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
MY104529A (en) New selenophen derivatives, a preparation process of the same and therapeutical compositions containing them
LU88449I2 (fr) Fleroxacine et ses dérivés pharmaceutiquement acceptables.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee